References
- Strasburger CJ, Jaursch-Hancke C, Kann PH, Klingmüller D, Plöckinger U, Petersenn S, Quabbe HJ. Missbräuchlicher Einsatz von humanem Wachstumshormon in der Anti-Aging-Medizin. Dtsch Arztebl 2002;99:A3177–80
- Neumann F, Schenk B, Schleusener H, Schweikert HU. Endokrinpharmakologie. In Forth W, Henschler D, Rummel W, Starke K, eds. Allgemeine und spezielle Pharmakologie und Toxikologie. Heidelberg, Berlin, Oxford: Spektrum Akademischer Verlag, 1996:581–637
- Stief CG, Ückert S, Becker AJ, Truss MC, Jonas U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. <i>J Urol1998;159:1390–3
- Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Synder SH. Nitric oxide: a physiologic mediator of penile erection. Science 1992;257:401–3
- Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic- noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991;88:112–18
- Burnett AL, Tillman SL, Chang TSK, Epstein JI, Lowenstein CJ, Bredt DS, Synder SH, Walsh PC. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol 1993;150:73–6
- Jung GW, Spencer EM, Lue TF. Growth hormone enhances regeneration of nitric oxide synthase- containing penile nerves after cavernous nerve neurotomy in rats. J Urol 1998;160:1899–904
- Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Mühlen A, Fröhlich C. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J Clin Invest 1996;98:2706–13